| Market Capitalization (Millions $) |
2 |
| Shares
Outstanding (Millions) |
1 |
| Employees |
14 |
| Revenues (TTM) (Millions $) |
0 |
| Net Income (TTM) (Millions $) |
-11 |
| Cash Flow (TTM) (Millions $) |
2 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Biorestorative Therapies Inc is a biotechnology company that focuses on developing and commercializing innovative therapies for various diseases and injuries. The company specializes in regenerative medicine, which involves using the body's own cells to repair damaged tissues and organs.
Biorestorative Therapies Inc's primary areas of focus include human cell and tissue products, bioartificial organs, and medical devices. Their therapies aim to address a wide range of conditions, such as cardiac and vascular diseases, metabolic disorders, neurodegenerative diseases, and orthopedic injuries.
The company's research and development efforts are dedicated to advancing stem cell-based technologies, including stem cell collection, isolation, expansion, and differentiation. Biorestorative Therapies Inc also seeks to enhance the delivery methods for stem cell therapies to improve their effectiveness and patient outcomes.
Overall, Biorestorative Therapies Inc aims to revolutionize the field of regenerative medicine by developing novel therapies that have the potential to change the standard of care for a variety of conditions.
Company Address: 40 Marcus Drive Melville 11747 NY
Company Phone Number: 760-8100 Stock Exchange / Ticker: NASDAQ BRTX
|
2.01% 
41.43 %